Tsuzuki T, Ogata Y, Iida S, Shimazu M
Arch Surg. 1984 Sep;119(9):1025-32. doi: 10.1001/archsurg.1984.01390210029008.
Hepatic resection was performed in 125 patients. Ninety-three of the 125 patients had malignant neoplasms; primary liver carcinoma in 61, metastatic liver carcinoma in 15, carcinoma of the bifurcation of the hepatic ducts in 16, and carcinoma of the gallbladder in one. Performance of hepatic resection was complicated by the presence of liver cirrhosis and jaundice in 42 and 19 patients, respectively. Nine of the 125 patients died within 30 days of the operations, with an operative mortality of 7.2%. Eight of the nine deaths were due to liver failure in the cirrhotic patients who underwent resection of more than two segments of the liver. None of the jaundiced patients died postoperatively. The three-year actuarial survival rates of the patients with hepatocellular carcinoma, metastatic liver carcinoma, and carcinoma of the bifurcation of the hepatic ducts were 31%, 56%, and 21% respectively.
125例患者接受了肝切除术。125例患者中有93例患有恶性肿瘤；其中原发性肝癌61例，转移性肝癌15例，肝门胆管癌16例，胆囊癌1例。分别有42例和19例患者因存在肝硬化和黄疸而使肝切除术的实施变得复杂。125例患者中有9例在术后30天内死亡，手术死亡率为7.2%。9例死亡患者中有8例是由于接受了超过两个肝段切除术的肝硬化患者出现肝衰竭。黄疸患者术后均未死亡。肝细胞癌、转移性肝癌和肝门胆管癌患者的三年精算生存率分别为31%、56%和21%。
